TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

Robert J Soiffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.